Collections

  • Supplement |

    In this era of minimally-invasive procedures for diagnosis, prognosis and treatment decisions, pathologists are asked to make more specific diagnoses from smaller samples. We asked top experts in their fields to discuss their strategies and most practical approaches to maximizing the information gained from limited specimens.

    Image: Filippone EJ, McCue PA, Farber JL. Mod Pathol. 2018
  • Supplement |

    The United States & Canadian Academy of Pathology annual meeting was held at the Vancouver Convention Centre, Vancouver, BC, Canada, March 17–23, 2018

  • Focus |

    The editors of Modern Pathology are pleased to present a selection of recent papers that focus on the diagnosis of gastrointestinal cancers from top international researchers in anatomic and molecular pathology. We present studies on prognostic markers of colorectal cancer and classification of gastric carcinoma, as well as research on the pathobiology of less common conditions such as colorectal mixed adenoneuroendocrine carcinoma, small intestinal adenocarcinoma and gastroblastoma.

  • Supplement |

    The United States & Canadian Academy of Pathology annual meeting was held at the Washington State Convention Center, Seattle, WA, March 12–18, 2016

  • Focus |

    Modern Pathology and Laboratory Investigation are proud to present a special Web Focus highlighting recent advances in breast cancer diagnosis and treatment. We feature papers that describe testing guidelines, recommendations for standardized pathological evaluation, optimal specimen handling and management, factors affecting recurrence rate, the promise of immune-based therapy, and more.

    Image: George F. Murphy
  • Focus |

    The heterogeneity and relative rarity of soft tissue sarcomas make them challenging targets for classification, biomarker identification, and development of improved treatment strategies. Laboratory Investigation and Modern Pathology are pleased to present a collection of recent articles that enhance our understanding of the pathogenesis of these tumors and describe advances that may lead to the development of new diagnostic tests and targeted therapies.

    Image: George F. Murphy